Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Heart and Renal Protection (SHARP): The Effects of Lowering LDL-cholesterol With Simvastatin 20mg Plus Ezetimibe 10mg in Patients With Chronic Kidney Disease: a Randomized Placebo-controlled Trial

NCT00125593 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00125593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Heart and Renal Protection (SHARP): The Effects of Lowering LDL-cholesterol With Simvastatin 20mg Plus Ezetimibe 10mg in Patients With Chronic Kidney Disease: a Randomized Placebo-controlled Trial
Lead sponsor
University of Oxford
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
August 31, 2010
Enrollment
9,438 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, chronic